Table 2.

Prevalence of Positive Screening Tests for Nephropathy and Peripheral Neuropathy in US Adults Aged ≥40 Years With Diagnosed Diabetes, Undiagnosed Diabetes, and No Diabetes

Screening TestNo Diabetes % (SE)Undiagnosed Diabetes % (SE)Diagnosed Diabetes % (SE)
* Difference vs undiagnosed diabetes group significant at P <.05.
† Estimates for peripheral neuropathy exclude participants with a history of stroke.
Nephropathy9.6 (0.6)*24.9 (4.4)28.0 (3.7)
Peripheral neuropathy10.1 (0.9)*21.5 (5.1)19.2 (3.4)